Long COVID and Post-infective Fatigue Syndrome: A Review
Abstract Fatigue is a dominant feature of both acute and convalescent coronavirus disease 2019 (COVID-19) (sometimes termed “long-COVID”), with up to 46% of patients reporting fatigue that lasts from weeks to months. The investigators of the international Collaborative on Fatigue Following Infection...
Saved in:
| Published in: | Open forum infectious diseases Vol. 8; no. 10; p. ofab440 |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
US
Oxford University Press
01.10.2021
|
| Subjects: | |
| ISSN: | 2328-8957, 2328-8957 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Abstract
Fatigue is a dominant feature of both acute and convalescent coronavirus disease 2019 (COVID-19) (sometimes termed “long-COVID”), with up to 46% of patients reporting fatigue that lasts from weeks to months. The investigators of the international Collaborative on Fatigue Following Infection (COFFI) conducted a systematic review of post-COVID fatigue and a narrative review on fatigue after other infections, and made recommendations for clinical and research approaches to assessing fatigue after COVID-19.
In the majority of COVID-19 cohort studies, persistent fatigue was reported by a significant minority of patients, ranging from 13% to 33% at 16–20 weeks post-symptom onset. Data from the prospective cohort studies in COFFI and others indicate that fatigue is also a prevalent outcome from many acute systemic infections, notably infectious mononucleosis, with a case rate for clinically significant Post-infective fatigue after exclusion of recognized medical and psychiatric causes, ranging from 10%–35% at 6 months.
To better characterize post-COVID fatigue, the COFFI investigators recommend the following: application of validated screening questionnaires for case detection; standardized interviews encompassing fatigue, mood, and other symptoms; and investigative approaches to identify end-organ damage and mental health conditions.
Fatigue after COVID-19 is common but generally resolves over months, like other postinfective fatigue states. Post-COVID fatigue results from end-organ injury, mental health conditions, or idiopathic post-COVID fatigue. Post-COVID fatigue should be assessed with validated questionnaires, interviews, and protocolized investigations. |
|---|---|
| AbstractList | Fatigue is a dominant feature of both acute and convalescent coronavirus disease 2019 (COVID-19) (sometimes termed “long-COVID”), with up to 46% of patients reporting fatigue that lasts from weeks to months. The investigators of the international Collaborative on Fatigue Following Infection (COFFI) conducted a systematic review of post-COVID fatigue and a narrative review on fatigue after other infections, and made recommendations for clinical and research approaches to assessing fatigue after COVID-19. In the majority of COVID-19 cohort studies, persistent fatigue was reported by a significant minority of patients, ranging from 13% to 33% at 16–20 weeks post-symptom onset. Data from the prospective cohort studies in COFFI and others indicate that fatigue is also a prevalent outcome from many acute systemic infections, notably infectious mononucleosis, with a case rate for clinically significant Post-infective fatigue after exclusion of recognized medical and psychiatric causes, ranging from 10%–35% at 6 months. To better characterize post-COVID fatigue, the COFFI investigators recommend the following: application of validated screening questionnaires for case detection; standardized interviews encompassing fatigue, mood, and other symptoms; and investigative approaches to identify end-organ damage and mental health conditions. Fatigue is a dominant feature of both acute and convalescent coronavirus disease 2019 (COVID-19) (sometimes termed "long-COVID"), with up to 46% of patients reporting fatigue that lasts from weeks to months. The investigators of the international Collaborative on Fatigue Following Infection (COFFI) conducted a systematic review of post-COVID fatigue and a narrative review on fatigue after other infections, and made recommendations for clinical and research approaches to assessing fatigue after COVID-19. In the majority of COVID-19 cohort studies, persistent fatigue was reported by a significant minority of patients, ranging from 13% to 33% at 16-20 weeks post-symptom onset. Data from the prospective cohort studies in COFFI and others indicate that fatigue is also a prevalent outcome from many acute systemic infections, notably infectious mononucleosis, with a case rate for clinically significant Post-infective fatigue after exclusion of recognized medical and psychiatric causes, ranging from 10%-35% at 6 months. To better characterize post-COVID fatigue, the COFFI investigators recommend the following: application of validated screening questionnaires for case detection; standardized interviews encompassing fatigue, mood, and other symptoms; and investigative approaches to identify end-organ damage and mental health conditions.Fatigue is a dominant feature of both acute and convalescent coronavirus disease 2019 (COVID-19) (sometimes termed "long-COVID"), with up to 46% of patients reporting fatigue that lasts from weeks to months. The investigators of the international Collaborative on Fatigue Following Infection (COFFI) conducted a systematic review of post-COVID fatigue and a narrative review on fatigue after other infections, and made recommendations for clinical and research approaches to assessing fatigue after COVID-19. In the majority of COVID-19 cohort studies, persistent fatigue was reported by a significant minority of patients, ranging from 13% to 33% at 16-20 weeks post-symptom onset. Data from the prospective cohort studies in COFFI and others indicate that fatigue is also a prevalent outcome from many acute systemic infections, notably infectious mononucleosis, with a case rate for clinically significant Post-infective fatigue after exclusion of recognized medical and psychiatric causes, ranging from 10%-35% at 6 months. To better characterize post-COVID fatigue, the COFFI investigators recommend the following: application of validated screening questionnaires for case detection; standardized interviews encompassing fatigue, mood, and other symptoms; and investigative approaches to identify end-organ damage and mental health conditions. Fatigue is a dominant feature of both acute and convalescent coronavirus disease 2019 (COVID-19) (sometimes termed “long-COVID”), with up to 46% of patients reporting fatigue that lasts from weeks to months. The investigators of the international Collaborative on Fatigue Following Infection (COFFI) conducted a systematic review of post-COVID fatigue and a narrative review on fatigue after other infections, and made recommendations for clinical and research approaches to assessing fatigue after COVID-19. In the majority of COVID-19 cohort studies, persistent fatigue was reported by a significant minority of patients, ranging from 13% to 33% at 16–20 weeks post-symptom onset. Data from the prospective cohort studies in COFFI and others indicate that fatigue is also a prevalent outcome from many acute systemic infections, notably infectious mononucleosis, with a case rate for clinically significant Post-infective fatigue after exclusion of recognized medical and psychiatric causes, ranging from 10%–35% at 6 months. To better characterize post-COVID fatigue, the COFFI investigators recommend the following: application of validated screening questionnaires for case detection; standardized interviews encompassing fatigue, mood, and other symptoms; and investigative approaches to identify end-organ damage and mental health conditions. Fatigue after COVID-19 is common but generally resolves over months, like other postinfective fatigue states. Post-COVID fatigue results from end-organ injury, mental health conditions, or idiopathic post-COVID fatigue. Post-COVID fatigue should be assessed with validated questionnaires, interviews, and protocolized investigations. Abstract Fatigue is a dominant feature of both acute and convalescent coronavirus disease 2019 (COVID-19) (sometimes termed “long-COVID”), with up to 46% of patients reporting fatigue that lasts from weeks to months. The investigators of the international Collaborative on Fatigue Following Infection (COFFI) conducted a systematic review of post-COVID fatigue and a narrative review on fatigue after other infections, and made recommendations for clinical and research approaches to assessing fatigue after COVID-19. In the majority of COVID-19 cohort studies, persistent fatigue was reported by a significant minority of patients, ranging from 13% to 33% at 16–20 weeks post-symptom onset. Data from the prospective cohort studies in COFFI and others indicate that fatigue is also a prevalent outcome from many acute systemic infections, notably infectious mononucleosis, with a case rate for clinically significant Post-infective fatigue after exclusion of recognized medical and psychiatric causes, ranging from 10%–35% at 6 months. To better characterize post-COVID fatigue, the COFFI investigators recommend the following: application of validated screening questionnaires for case detection; standardized interviews encompassing fatigue, mood, and other symptoms; and investigative approaches to identify end-organ damage and mental health conditions. Fatigue after COVID-19 is common but generally resolves over months, like other postinfective fatigue states. Post-COVID fatigue results from end-organ injury, mental health conditions, or idiopathic post-COVID fatigue. Post-COVID fatigue should be assessed with validated questionnaires, interviews, and protocolized investigations. Fatigue is a dominant feature of both acute and convalescent coronavirus disease 2019 (COVID-19) (sometimes termed “long-COVID”), with up to 46% of patients reporting fatigue that lasts from weeks to months. The investigators of the international Collaborative on Fatigue Following Infection (COFFI) conducted a systematic review of post-COVID fatigue and a narrative review on fatigue after other infections, and made recommendations for clinical and research approaches to assessing fatigue after COVID-19. In the majority of COVID-19 cohort studies, persistent fatigue was reported by a significant minority of patients, ranging from 13% to 33% at 16–20 weeks post-symptom onset. Data from the prospective cohort studies in COFFI and others indicate that fatigue is also a prevalent outcome from many acute systemic infections, notably infectious mononucleosis, with a case rate for clinically significant Post-infective fatigue after exclusion of recognized medical and psychiatric causes, ranging from 10%–35% at 6 months. To better characterize post-COVID fatigue, the COFFI investigators recommend the following: application of validated screening questionnaires for case detection; standardized interviews encompassing fatigue, mood, and other symptoms; and investigative approaches to identify end-organ damage and mental health conditions. |
| Author | Sandler, Carolina X Taylor, Renee Katz, Ben Z Buchwald, Dedra Little, Paul Moss-Morris, Rona Crawley, Esther Wyller, Vegard B B Hautvast, Jeannine Knoop, Hans Wensaas, Knut-Arne Lloyd, Andrew R |
| AuthorAffiliation | 13 Research Unit for General Practice, NORCE Norwegian Research Centre , Bergen , Norway 11 Primary Care Research Centre, Primary Care Public Health and Medical Education Unit, Faculty of Medicine, University of Southampton , United Kingdom 7 Department of Primary and Community Care, Radboud University Medical Center , Nijmegen, Nijmegen , Netherlands 1 The Kirby Institute, UNSW Sydney , New South Wales , Australia 5 Institute for Research and Education to Advance Community Health, Washington State University , Seattle, Washington , USA 12 College of Applied Health Sciences, University of Illinois at Chicago , Chicago, Illinois , USA 4 Health Psychology, Institute of Psychiatry, Psychology and Neuroscience , King’s College London, London , United Kingdom 6 Bristol Medical School, University of Bristol. Bristol. Centre for Academic Child Health , Bristol , United Kingdom 8 Northwestern University Feinberg School of Medicine, Chicago , Department of Pediatrics, Chicago, Illinois , USA 9 Ann & Rob |
| AuthorAffiliation_xml | – name: 5 Institute for Research and Education to Advance Community Health, Washington State University , Seattle, Washington , USA – name: 6 Bristol Medical School, University of Bristol. Bristol. Centre for Academic Child Health , Bristol , United Kingdom – name: 2 Department of Pediatrics and Adolescent Medicine, Akershus University Hospital , Lørenskog , Norway – name: 11 Primary Care Research Centre, Primary Care Public Health and Medical Education Unit, Faculty of Medicine, University of Southampton , United Kingdom – name: 13 Research Unit for General Practice, NORCE Norwegian Research Centre , Bergen , Norway – name: 8 Northwestern University Feinberg School of Medicine, Chicago , Department of Pediatrics, Chicago, Illinois , USA – name: 7 Department of Primary and Community Care, Radboud University Medical Center , Nijmegen, Nijmegen , Netherlands – name: 10 Department of Medical Psychology, Amsterdam University Medical Centers, Amsterdam Public Health Research Institute, University of Amsterdam , Amsterdam , Netherlands – name: 4 Health Psychology, Institute of Psychiatry, Psychology and Neuroscience , King’s College London, London , United Kingdom – name: 12 College of Applied Health Sciences, University of Illinois at Chicago , Chicago, Illinois , USA – name: 1 The Kirby Institute, UNSW Sydney , New South Wales , Australia – name: 3 Institute of Clinical Medicine, University of Oslo, Blindern , Oslo , Norway – name: 9 Ann & Robert H Lurie Children’s Hospital of Chicago , Division of Infectious Diseases, Chicago, Illinois , USA |
| Author_xml | – sequence: 1 givenname: Carolina X surname: Sandler fullname: Sandler, Carolina X organization: The Kirby Institute, UNSW Sydney, New South Wales, Australia – sequence: 2 givenname: Vegard B B surname: Wyller fullname: Wyller, Vegard B B organization: Department of Pediatrics and Adolescent Medicine, Akershus University Hospital, Lørenskog, Norway – sequence: 3 givenname: Rona surname: Moss-Morris fullname: Moss-Morris, Rona organization: Health Psychology, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom – sequence: 4 givenname: Dedra surname: Buchwald fullname: Buchwald, Dedra organization: Institute for Research and Education to Advance Community Health, Washington State University, Seattle, Washington, USA – sequence: 5 givenname: Esther surname: Crawley fullname: Crawley, Esther organization: Bristol Medical School, University of Bristol. Bristol. Centre for Academic Child Health, Bristol, United Kingdom – sequence: 6 givenname: Jeannine surname: Hautvast fullname: Hautvast, Jeannine organization: Department of Primary and Community Care, Radboud University Medical Center, Nijmegen, Nijmegen, Netherlands – sequence: 7 givenname: Ben Z surname: Katz fullname: Katz, Ben Z organization: Northwestern University Feinberg School of Medicine, Chicago, Department of Pediatrics, Chicago, Illinois, USA – sequence: 8 givenname: Hans surname: Knoop fullname: Knoop, Hans organization: Department of Medical Psychology, Amsterdam University Medical Centers, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, Netherlands – sequence: 9 givenname: Paul surname: Little fullname: Little, Paul organization: Primary Care Research Centre, Primary Care Public Health and Medical Education Unit, Faculty of Medicine, University of Southampton, United Kingdom – sequence: 10 givenname: Renee surname: Taylor fullname: Taylor, Renee organization: College of Applied Health Sciences, University of Illinois at Chicago, Chicago, Illinois, USA – sequence: 11 givenname: Knut-Arne surname: Wensaas fullname: Wensaas, Knut-Arne organization: Research Unit for General Practice, NORCE Norwegian Research Centre, Bergen, Norway – sequence: 12 givenname: Andrew R orcidid: 0000-0001-6277-8887 surname: Lloyd fullname: Lloyd, Andrew R email: a.lloyd@unsw.edu.au organization: The Kirby Institute, UNSW Sydney, New South Wales, Australia |
| BookMark | eNp9kVtLAzEQhYMo1tubP2DBB31wNZPsJfFBKNWqUFC8vYbs7myNbJO62a3037ulFbSgL5lAvjmTM2eXbFpnkZBDoGdAJT93pSm6Q2dRRDfIDuNMhELG6eaPe48ceP9OKQWgMU3lNunxKOEgIdkhYuTsOBjcv95dBdoWwYPzTWhsiXljZhgMdWPGLQZPc1vUboIXQT94xJnBz32yVerK48Gq7pGX4fXz4DYc3d_cDfqjMI9E2oSxwAR0xjlgoTFlDEqIUWSQUU4zEJpnJQBDyGMuaZ4lRfezMi25FFIjL_geuVzqTttsgkWOtql1paa1meh6rpw26veLNW9q7GZKRDJJk7gTOFkJ1O6jRd-oifE5VpW26FqvWCyojCXAAj1aQ99dW9vOnuKQUplIBqyj2JLKa-d9jaXKTdPtyS3mm0oBVYts1CIbtcqmazpda_p28Ad-vMRdO_2f_AJx6p7v |
| CitedBy_id | crossref_primary_10_1080_16506073_2024_2360054 crossref_primary_10_1016_j_amjmed_2024_02_003 crossref_primary_10_1093_ofid_ofad277 crossref_primary_10_1055_s_0043_1767781 crossref_primary_10_1080_14737175_2023_2239500 crossref_primary_10_1371_journal_pone_0292928 crossref_primary_10_3390_biomedicines12061234 crossref_primary_10_1136_jnnp_2024_333950 crossref_primary_10_1177_11795735221102727 crossref_primary_10_3390_ijerph19116811 crossref_primary_10_1093_braincomms_fcaf315 crossref_primary_10_1093_cid_ciac966 crossref_primary_10_1136_postgradmedj_2021_141429 crossref_primary_10_1080_15502783_2025_2517278 crossref_primary_10_1007_s11121_025_01784_0 crossref_primary_10_3390_antiox14091068 crossref_primary_10_3389_fimmu_2022_837288 crossref_primary_10_1542_peds_2023_062570 crossref_primary_10_3390_nu14030689 crossref_primary_10_1093_jnci_djac057 crossref_primary_10_1001_jamanetworkopen_2023_5763 crossref_primary_10_1002_ptr_8096 crossref_primary_10_3390_ijerph181910271 crossref_primary_10_3390_jpm15060217 crossref_primary_10_1016_j_nrleng_2025_02_002 crossref_primary_10_1080_21641846_2025_2531728 crossref_primary_10_3390_v16081266 crossref_primary_10_1097_j_pain_0000000000002711 crossref_primary_10_1016_j_imr_2024_101039 crossref_primary_10_1177_13872877241303934 crossref_primary_10_1016_j_jns_2023_120827 crossref_primary_10_3390_microorganisms13040702 crossref_primary_10_1136_bmjopen_2022_069217 crossref_primary_10_1007_s10238_023_01057_6 crossref_primary_10_1136_bmj_2024_081349 crossref_primary_10_1016_j_nrl_2023_09_001 crossref_primary_10_3390_jcm11206214 crossref_primary_10_2147_IDR_S355064 crossref_primary_10_3390_jcm12041536 crossref_primary_10_1111_apa_70034 crossref_primary_10_1016_j_apmr_2024_01_007 crossref_primary_10_1186_s12916_023_03083_3 crossref_primary_10_3390_jcm12144737 crossref_primary_10_1016_j_bbih_2024_100889 crossref_primary_10_3390_jcm14020378 crossref_primary_10_7759_cureus_39722 crossref_primary_10_1016_j_berh_2022_101794 crossref_primary_10_3390_covid5080136 crossref_primary_10_3389_fmed_2024_1387499 crossref_primary_10_1016_j_cmi_2022_01_014 crossref_primary_10_3390_v14051082 crossref_primary_10_1007_s00415_024_12212_8 crossref_primary_10_1017_neu_2022_21 crossref_primary_10_3390_biomedicines13010069 crossref_primary_10_7759_cureus_31281 crossref_primary_10_1016_j_jbspin_2023_105623 crossref_primary_10_1186_s41687_023_00570_2 crossref_primary_10_3390_ijms232314532 crossref_primary_10_1016_j_ero_2025_03_003 crossref_primary_10_1016_j_amjmed_2023_06_028 crossref_primary_10_1097_MJT_0000000000001459 crossref_primary_10_3390_jcm12072517 crossref_primary_10_1080_13854046_2024_2344455 crossref_primary_10_3390_nu14153027 crossref_primary_10_1371_journal_pone_0294261 crossref_primary_10_1136_bmjmed_2022_000385 crossref_primary_10_1007_s11055_023_01470_0 crossref_primary_10_3390_jpm13091369 crossref_primary_10_1016_j_pmr_2023_04_006 crossref_primary_10_3390_ijms25169050 crossref_primary_10_7759_cureus_36325 crossref_primary_10_1016_j_ajic_2022_09_007 crossref_primary_10_1017_neu_2024_10 crossref_primary_10_2147_NDT_S451031 crossref_primary_10_3390_v15020400 crossref_primary_10_1007_s00221_022_06518_0 crossref_primary_10_1016_S1470_2045_23_00056_6 crossref_primary_10_17116_jnevro202512503244 crossref_primary_10_1007_s00508_023_02204_5 crossref_primary_10_3389_fneur_2022_935442 crossref_primary_10_1016_j_bbr_2023_114662 crossref_primary_10_1097_MJT_0000000000001483 crossref_primary_10_1186_s12982_024_00333_4 crossref_primary_10_3390_vaccines11121769 crossref_primary_10_3389_fnmol_2022_870868 crossref_primary_10_3390_children11050532 crossref_primary_10_3390_jcm13123383 crossref_primary_10_1007_s00415_022_11141_8 crossref_primary_10_2196_40028 crossref_primary_10_1371_journal_pone_0269954 crossref_primary_10_1177_20499361231198335 crossref_primary_10_1371_journal_pone_0293023 crossref_primary_10_1097_INF_0000000000003976 crossref_primary_10_1136_bmjopen_2023_072611 crossref_primary_10_3389_fimmu_2023_1254899 crossref_primary_10_1016_j_ejca_2022_03_019 crossref_primary_10_1016_j_amjmed_2024_04_041 crossref_primary_10_1038_s41598_022_14787_6 crossref_primary_10_3389_fneur_2022_915712 crossref_primary_10_1097_MJT_0000000000001471 crossref_primary_10_1007_s40620_022_01295_z crossref_primary_10_1007_s11886_022_01786_2 crossref_primary_10_1007_s12369_023_01072_3 crossref_primary_10_1097_MJT_0000000000001475 crossref_primary_10_2196_50230 crossref_primary_10_1186_s12967_023_04587_5 crossref_primary_10_3390_brainsci13030444 crossref_primary_10_1177_10815589231212899 crossref_primary_10_3390_ijerph191610362 crossref_primary_10_5585_23_2024_26134 crossref_primary_10_1093_cid_ciad045 crossref_primary_10_3390_ijms232213683 crossref_primary_10_3390_nu14214701 crossref_primary_10_1371_journal_pone_0309348 crossref_primary_10_1111_joim_13720 crossref_primary_10_3389_fmed_2023_1179783 crossref_primary_10_1016_j_bbii_2023_100022 crossref_primary_10_1016_j_bbih_2025_100982 crossref_primary_10_3389_fphys_2022_833650 crossref_primary_10_1186_s12913_022_08174_0 crossref_primary_10_46932_sfjdv6n9_018 crossref_primary_10_3389_fdgth_2025_1504217 crossref_primary_10_1016_j_idnow_2022_02_005 crossref_primary_10_3390_biomedicines12081650 crossref_primary_10_3390_jcm12020511 crossref_primary_10_1016_j_jiph_2025_102652 crossref_primary_10_3390_jcm13041147 crossref_primary_10_1097_JOM_0000000000003413 crossref_primary_10_1183_16000617_0110_2023 crossref_primary_10_1136_bmjopen_2023_075301 crossref_primary_10_3389_fpubh_2023_1241401 crossref_primary_10_3390_life13071558 crossref_primary_10_7759_cureus_92535 crossref_primary_10_1136_bmjph_2023_000102 crossref_primary_10_3390_jcm14165782 crossref_primary_10_3390_nu14061305 crossref_primary_10_3390_biomedicines13081801 crossref_primary_10_1016_j_amjmed_2023_09_013 crossref_primary_10_1186_s12967_024_05117_7 crossref_primary_10_3390_medicina58060828 |
| Cites_doi | 10.1016/j.jinf.2020.08.029 10.1093/ofid/ofaa507 10.1086/500248 10.1371/journal.pone.0239235 10.1176/appi.ajp.160.2.221 10.1093/qjmed/hcaa178 10.1016/j.jpsychores.2017.06.013 10.1016/j.rmed.2020.106197 10.1097/PSY.0000000000000061 10.1093/cid/ciaa1886 10.3389/fpubh.2020.00152 10.1016/j.jpsychores.2020.110154 10.1186/1479-5876-10-191 10.1016/S2215-0366(21)00084-5 10.1001/archinte.1993.00410240067007 10.1136/jech.2003.008466 10.1093/qjmed/hcw041 10.7326/0003-4819-121-12-199412150-00009 10.3346/jkms.2020.35.e418 10.1038/s41586-021-03553-9 10.3399/bjgpopen20X101143 10.1136/thoraxjnl-2020-215818 10.1371/journal.pone.0241537 10.1186/s12865-017-0190-3 10.1016/j.cmi.2020.09.023 10.1002/jmv.21873 10.1371/journal.pone.0243882 10.1038/nrendo.2011.153 10.1017/S0033291701003841 10.1016/S0140-6736(95)92537-6 10.1016/j.bbi.2019.07.034 10.1097/MD.0000000000017600 10.1097/00006842-199905000-00009 10.5664/jcsm.2276 10.1111/ijcp.13746 10.1016/j.cmi.2020.09.052 10.1093/brain/awx153 10.1016/j.bbi.2011.12.009 10.1001/jama.2020.12603 10.1002/jmv.26368 10.1371/journal.pone.0240784 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2021 The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. |
| Copyright_xml | – notice: The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2021 – notice: The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. |
| DBID | TOX AAYXX CITATION 3V. 7X7 7XB 8C1 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM |
| DOI | 10.1093/ofid/ofab440 |
| DatabaseName | Oxford Journals Open Access Collection CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central (subscription) ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef Publicly Available Content Database ProQuest Public Health ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic CrossRef |
| Database_xml | – sequence: 1 dbid: TOX name: Oxford Journals Open Access Collection url: https://academic.oup.com/journals/ sourceTypes: Publisher – sequence: 2 dbid: PIMPY name: ProQuest Publicly Available Content url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2328-8957 |
| ExternalDocumentID | PMC8496765 10_1093_ofid_ofab440 10.1093/ofid/ofab440 |
| GrantInformation_xml | – fundername: ; – fundername: ; grantid: 1041897 |
| GroupedDBID | 0R~ 53G 5VS AAFWJ AAMVS AAPPN AAPXW AAVAP ABDBF ABPTD ABXVV ACGFS ADBBV ADHZD ADPDF ADRAZ AENZO AFPKN AFULF ALMA_UNASSIGNED_HOLDINGS ALUQC AOIJS BAWUL BAYMD BCNDV BTTYL CIDKT DIK EBS EJD GROUPED_DOAJ H13 HYE IAO KQ8 KSI M48 M~E O9- OAWHX OJQWA OK1 OVD OVEED PEELM ROL ROX RPM TEORI TJX TOX 7X7 8C1 8FI 8FJ AAYXX ABEJV ABGNP ABUWG ACUHS AFFHD AFKRA AMNDL BENPR CCPQU CITATION FYUFA HMCUK IHR ITC PHGZM PHGZT PIMPY PJZUB PPXIY UKHRP 3V. 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQQKQ PQUKI 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c487t-58e61ab331edae7221f15e8b1b030b18a3bf112e1c5390cb6d631f7f3989ae3d3 |
| IEDL.DBID | BENPR |
| ISICitedReferencesCount | 145 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000713697800013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2328-8957 |
| IngestDate | Tue Nov 04 02:01:24 EST 2025 Thu Oct 02 05:20:08 EDT 2025 Tue Oct 07 07:20:55 EDT 2025 Sat Nov 29 01:54:41 EST 2025 Tue Nov 18 22:18:26 EST 2025 Wed Aug 28 03:17:23 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 10 |
| Keywords | COVID-19 assessment fatigue post-viral cohorts |
| Language | English |
| License | This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com https://creativecommons.org/licenses/by-nc-nd/4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c487t-58e61ab331edae7221f15e8b1b030b18a3bf112e1c5390cb6d631f7f3989ae3d3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0001-6277-8887 |
| OpenAccessLink | https://www.proquest.com/docview/3170969212?pq-origsite=%requestingapplication% |
| PMID | 34631916 |
| PQID | 3170969212 |
| PQPubID | 7089189 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8496765 proquest_miscellaneous_2580959115 proquest_journals_3170969212 crossref_citationtrail_10_1093_ofid_ofab440 crossref_primary_10_1093_ofid_ofab440 oup_primary_10_1093_ofid_ofab440 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-10-01 |
| PublicationDateYYYYMMDD | 2021-10-01 |
| PublicationDate_xml | – month: 10 year: 2021 text: 2021-10-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | US |
| PublicationPlace_xml | – name: US – name: Oxford |
| PublicationTitle | Open forum infectious diseases |
| PublicationYear | 2021 |
| Publisher | Oxford University Press |
| Publisher_xml | – name: Oxford University Press |
| References | Halpin (2021100717173377800_CIT0015) 2021; 93 Bennett (2021100717173377800_CIT0006) 2014; 76 Kamal (2021100717173377800_CIT0024) 2021; 75 Bates (2021100717173377800_CIT0034) 1993; 153 Fukuda (2021100717173377800_CIT0007) 1994; 121 Pilotto (2021100717173377800_CIT0029) 2021 Kuppuswamy (2021100717173377800_CIT0003) 2017; 140 Darley (2021100717173377800_CIT0022) 2020 Hulme (2021100717173377800_CIT0036) 2017; 99 Carfì (2021100717173377800_CIT0013) 2020; 324 Sudre (2021100717173377800_CIT0010) 2021 Cameron (2021100717173377800_CIT0039) 2006; 193 Carvalho-Schneider (2021100717173377800_CIT0009) 2021; 27 Piraino (2021100717173377800_CIT0045) 2012; 26 Xiong (2021100717173377800_CIT0020) 2021; 27 Savarraj (2021100717173377800_CIT0018) 2020 Wessely (2021100717173377800_CIT0035) 1995; 345 Garrigues (2021100717173377800_CIT0014) 2020; 81 Mandal (2021100717173377800_CIT0026) 2021; 76 Afari (2021100717173377800_CIT0051) 2003; 160 Kingstone (2021100717173377800_CIT0044) 2020; 4 Townsend (2021100717173377800_CIT0019) 2020; 15 Jacobs (2021100717173377800_CIT0023) 2020; 15 Miyazato (2021100717173377800_CIT0016) 2020; 7 Al-Aly (2021100717173377800_CIT0033) 2021; 594 Papadopoulos (2021100717173377800_CIT0050) 2011; 8 Wang (2021100717173377800_CIT0011) 2020; 113 Sami (2021100717173377800_CIT0028) 2020; 15 Jin (2021100717173377800_CIT0031) 2020; 8 Jason (2021100717173377800_CIT0037) 2020 Cvejic (2021100717173377800_CIT0046) 2019; 82 Baig (2021100717173377800_CIT0001) 2020 Liang (2021100717173377800_CIT0025) 2020; 35 Theorell (2021100717173377800_CIT0047) 1999; 61 Qi (2021100717173377800_CIT0017) 2020 Delgado-Rodríguez (2021100717173377800_CIT0030) 2004; 58 National Institute for Health and Care Excellence. (2021100717173377800_CIT0043) Katz (2021100717173377800_CIT0005) 2018; 6 Broderick (2021100717173377800_CIT0040) 2012; 10 Daher (2021100717173377800_CIT0021) 2020; 174 Time. (2021100717173377800_CIT0002) Hopper (2021100717173377800_CIT0038) 2016; 109 Nelson (2021100717173377800_CIT0049) 2019; 98 Borges do Nascimento (2021100717173377800_CIT0008) 2020; 15 Jackson (2021100717173377800_CIT0048) 2012; 8 Petersen (2021100717173377800_CIT0027) 2020 Taquet (2021100717173377800_CIT0032) 2021; 8 Vollmer-Conna (2021100717173377800_CIT0004) 2001; 31 King (2021100717173377800_CIT0052) 2020; 135 Cameron (2021100717173377800_CIT0042) 2010; 82 Arnold (2021100717173377800_CIT0012) 2020 Hanevik (2021100717173377800_CIT0041) 2017; 18 |
| References_xml | – volume: 81 start-page: e4 year: 2020 ident: 2021100717173377800_CIT0014 article-title: Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19 publication-title: J Infect doi: 10.1016/j.jinf.2020.08.029 – volume: 7 start-page: ofaa507 year: 2020 ident: 2021100717173377800_CIT0016 article-title: Prolonged and late-onset symptoms of coronavirus disease 2019 publication-title: Open Forum Infect Dis doi: 10.1093/ofid/ofaa507 – volume: 193 start-page: 664 year: 2006 ident: 2021100717173377800_CIT0039 article-title: Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load publication-title: J Infect Dis doi: 10.1086/500248 – volume: 15 start-page: e0239235 year: 2020 ident: 2021100717173377800_CIT0008 article-title: Clinical, laboratory and radiological characteristics and outcomes of novel coronavirus (SARS-CoV-2) infection in humans: a systematic review and series of meta-analyses publication-title: PLoS One doi: 10.1371/journal.pone.0239235 – volume: 160 start-page: 221 year: 2003 ident: 2021100717173377800_CIT0051 article-title: Chronic fatigue syndrome: a review publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.160.2.221 – volume: 113 start-page: 657 year: 2020 ident: 2021100717173377800_CIT0011 article-title: Clinical features and outcomes of discharged coronavirus disease 2019 patients: a prospective cohort study publication-title: QJM doi: 10.1093/qjmed/hcaa178 – volume: 99 start-page: 120 year: 2017 ident: 2021100717173377800_CIT0036 article-title: Biopsychosocial risk factors of persistent fatigue after acute infection: a systematic review to inform interventions publication-title: J Psychosom Res doi: 10.1016/j.jpsychores.2017.06.013 – volume: 174 start-page: 106197 year: 2020 ident: 2021100717173377800_CIT0021 article-title: Follow up of patients with severe coronavirus disease 2019 (COVID-19): pulmonary and extrapulmonary disease sequelae publication-title: Respir Med doi: 10.1016/j.rmed.2020.106197 – volume: 76 start-page: 379 year: 2014 ident: 2021100717173377800_CIT0006 article-title: Characterization of fatigue states in medicine and psychiatry by structured interview publication-title: Psychosom Med doi: 10.1097/PSY.0000000000000061 – year: 2020 ident: 2021100717173377800_CIT0037 article-title: Risks for developing ME/CFS in college students following infectious mononucleosis: a prospective cohort study publication-title: Clin Infect Dis doi: 10.1093/cid/ciaa1886 – volume: 8 start-page: 152 year: 2020 ident: 2021100717173377800_CIT0031 article-title: Gender differences in patients with COVID-19: focus on severity and mortality publication-title: Front Public Health doi: 10.3389/fpubh.2020.00152 – volume: 135 start-page: 110154 year: 2020 ident: 2021100717173377800_CIT0052 article-title: Patterns of daytime physical activity in patients with chronic fatigue syndrome publication-title: J Psychosom Res doi: 10.1016/j.jpsychores.2020.110154 – volume: 10 start-page: 191 year: 2012 ident: 2021100717173377800_CIT0040 article-title: Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue publication-title: J Transl Med doi: 10.1186/1479-5876-10-191 – volume: 8 start-page: 416 year: 2021 ident: 2021100717173377800_CIT0032 article-title: 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(21)00084-5 – volume: 153 start-page: 2759 year: 1993 ident: 2021100717173377800_CIT0034 article-title: Prevalence of fatigue and chronic fatigue syndrome in a primary care practice publication-title: Arch Intern Med doi: 10.1001/archinte.1993.00410240067007 – volume: 58 start-page: 635 year: 2004 ident: 2021100717173377800_CIT0030 article-title: Bias publication-title: J Epidemiol Community Health doi: 10.1136/jech.2003.008466 – volume: 109 start-page: 661 year: 2016 ident: 2021100717173377800_CIT0038 article-title: The natural history of acute Q fever: a prospective Australian cohort publication-title: QJM doi: 10.1093/qjmed/hcw041 – volume: 121 start-page: 953 year: 1994 ident: 2021100717173377800_CIT0007 article-title: The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group publication-title: Ann Intern Med doi: 10.7326/0003-4819-121-12-199412150-00009 – volume: 35 start-page: e418 year: 2020 ident: 2021100717173377800_CIT0025 article-title: Three-month follow-up study of survivors of Coronavirus disease 2019 after discharge publication-title: J Korean Med Sci doi: 10.3346/jkms.2020.35.e418 – volume: 594 start-page: 259 year: 2021 ident: 2021100717173377800_CIT0033 article-title: High-dimensional characterization of post-acute sequelae of COVID-19 publication-title: Nature doi: 10.1038/s41586-021-03553-9 – volume: 4 year: 2020 ident: 2021100717173377800_CIT0044 article-title: Finding the ‘right’ GP: a qualitative study of the experiences of people with long-COVID publication-title: BJGP Open doi: 10.3399/bjgpopen20X101143 – volume: 76 start-page: 396 year: 2021 ident: 2021100717173377800_CIT0026 article-title: ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19 publication-title: Thorax doi: 10.1136/thoraxjnl-2020-215818 – ident: 2021100717173377800_CIT0002 – volume: 15 start-page: e0241537 year: 2020 ident: 2021100717173377800_CIT0028 article-title: A one-year hospital-based prospective COVID-19 open-cohort in the Eastern Mediterranean region: the Khorshid COVID Cohort (KCC) study publication-title: PLoS One doi: 10.1371/journal.pone.0241537 – volume: 18 start-page: 5 year: 2017 ident: 2021100717173377800_CIT0041 article-title: Giardia-specific cellular immune responses in post-giardiasis chronic fatigue syndrome publication-title: BMC Immunol doi: 10.1186/s12865-017-0190-3 – volume: 27 start-page: 89 year: 2021 ident: 2021100717173377800_CIT0020 article-title: Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study publication-title: Clin Microbiol Infect doi: 10.1016/j.cmi.2020.09.023 – year: 2020 ident: 2021100717173377800_CIT0012 article-title: Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort publication-title: Thorax – volume: 82 start-page: 1684 year: 2010 ident: 2021100717173377800_CIT0042 article-title: Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome publication-title: J Med Virol doi: 10.1002/jmv.21873 – volume: 15 start-page: e0243882 year: 2020 ident: 2021100717173377800_CIT0023 article-title: Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection publication-title: PLoS One doi: 10.1371/journal.pone.0243882 – volume: 8 start-page: 22 year: 2011 ident: 2021100717173377800_CIT0050 article-title: Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome publication-title: Nat Rev Endocrinol doi: 10.1038/nrendo.2011.153 – volume: 31 start-page: 761 year: 2001 ident: 2021100717173377800_CIT0004 article-title: Acute sickness behaviour: an immune system-to-brain communication? publication-title: Psychol Med doi: 10.1017/S0033291701003841 – start-page: ; 93:2555–6 year: 2020 ident: 2021100717173377800_CIT0001 article-title: Chronic COVID syndrome: need for an appropriate publication-title: J Med Virol – volume: 345 start-page: 1333 year: 1995 ident: 2021100717173377800_CIT0035 article-title: Postinfectious fatigue: prospective cohort study in primary care publication-title: Lancet doi: 10.1016/S0140-6736(95)92537-6 – volume: 82 start-page: 76 year: 2019 ident: 2021100717173377800_CIT0046 article-title: Contribution of individual psychological and psychosocial factors to symptom severity and time-to-recovery after naturally-occurring acute infective illness: the Dubbo Infection Outcomes Study (DIOS) publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2019.07.034 – volume: 98 start-page: e17600 year: 2019 ident: 2021100717173377800_CIT0049 article-title: Evidence of altered cardiac autonomic regulation in myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review and meta-analysis publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000017600 – start-page: ; 27:626–31 year: 2021 ident: 2021100717173377800_CIT0010 article-title: Attributes and predictors of long COVID publication-title: Nat Med – volume: 61 start-page: 304 year: 1999 ident: 2021100717173377800_CIT0047 article-title: Critical life events, infections, and symptoms during the year preceding chronic fatigue syndrome (CFS): an examination of CFS patients and subjects with a nonspecific life crisis publication-title: Psychosom Med doi: 10.1097/00006842-199905000-00009 – volume: 8 start-page: 719 year: 2012 ident: 2021100717173377800_CIT0048 article-title: Sleep abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: a review publication-title: J Clin Sleep Med doi: 10.5664/jcsm.2276 – volume: 75 start-page: e13746 year: 2021 ident: 2021100717173377800_CIT0024 article-title: Assessment and characterisation of post-COVID-19 manifestations publication-title: Int J Clin Pract doi: 10.1111/ijcp.13746 – volume: 27 start-page: 258 year: 2021 ident: 2021100717173377800_CIT0009 article-title: Follow-up of adults with noncritical COVID-19 two months after symptom onset publication-title: Clin Microbiol Infect doi: 10.1016/j.cmi.2020.09.052 – start-page: .10.16.20211029; year: 2020 ident: 2021100717173377800_CIT0018 article-title: Three-month outcomes in hospitalized COVID-19 patients [preprint publication-title: medRxiv – volume: 140 start-page: 2240 year: 2017 ident: 2021100717173377800_CIT0003 article-title: The fatigue conundrum publication-title: Brain doi: 10.1093/brain/awx153 – volume: 26 start-page: 552 year: 2012 ident: 2021100717173377800_CIT0045 article-title: Genetic associations of fatigue and other symptom domains of the acute sickness response to infection publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2011.12.009 – year: 2020 ident: 2021100717173377800_CIT0027 article-title: Long publication-title: Clin Infect Dis – ident: 2021100717173377800_CIT0043 – start-page: :1–5 year: 2021 ident: 2021100717173377800_CIT0029 article-title: Long-term neurological manifestations of COVID-19: prevalence and predictive factors publication-title: Neurol Sci – volume: 6 start-page: 106 year: 2018 ident: 2021100717173377800_CIT0005 article-title: The international Collaborative on Fatigue Following Infection (COFFI) publication-title: Fatigue – volume: 324 start-page: 603 year: 2020 ident: 2021100717173377800_CIT0013 article-title: Persistent symptoms in patients after acute COVID-19 publication-title: JAMA doi: 10.1001/jama.2020.12603 – volume: 93 start-page: 1013 year: 2021 ident: 2021100717173377800_CIT0015 article-title: Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation publication-title: J Med Virol doi: 10.1002/jmv.26368 – year: 2020 ident: 2021100717173377800_CIT0017 article-title: Psychological morbidities and fatigue in patients with confirmed COVID-19 during disease outbreak: prevalence and associated biopsychosocial risk factors publication-title: Preprint. medRxiv. 2020;2020.05.08.20031666. Published May 11 – start-page: ; 214:279–80 year: 2020 ident: 2021100717173377800_CIT0022 article-title: High rate of persistent symptoms up to 4 months after community and hospital-managed SARS-CoV-2 infection publication-title: Med J Aust – volume: 15 start-page: e0240784 year: 2020 ident: 2021100717173377800_CIT0019 article-title: Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection publication-title: PLoS One doi: 10.1371/journal.pone.0240784 |
| SSID | ssj0001105079 |
| Score | 2.5743024 |
| SecondaryResourceType | review_article |
| Snippet | Abstract
Fatigue is a dominant feature of both acute and convalescent coronavirus disease 2019 (COVID-19) (sometimes termed “long-COVID”), with up to 46% of... Fatigue is a dominant feature of both acute and convalescent coronavirus disease 2019 (COVID-19) (sometimes termed “long-COVID”), with up to 46% of patients... Fatigue is a dominant feature of both acute and convalescent coronavirus disease 2019 (COVID-19) (sometimes termed "long-COVID"), with up to 46% of patients... |
| SourceID | pubmedcentral proquest crossref oup |
| SourceType | Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
| StartPage | ofab440 |
| SubjectTerms | Cohort analysis Coronaviruses COVID-19 Editor's Choice Review |
| Title | Long COVID and Post-infective Fatigue Syndrome: A Review |
| URI | https://www.proquest.com/docview/3170969212 https://www.proquest.com/docview/2580959115 https://pubmed.ncbi.nlm.nih.gov/PMC8496765 |
| Volume | 8 |
| WOSCitedRecordID | wos000713697800013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2328-8957 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001105079 issn: 2328-8957 databaseCode: DOA dateStart: 20140101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2328-8957 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001105079 issn: 2328-8957 databaseCode: M~E dateStart: 20140101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVASL databaseName: Oxford Journals Open Access Collection customDbUrl: eissn: 2328-8957 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001105079 issn: 2328-8957 databaseCode: TOX dateStart: 20140101 isFulltext: true titleUrlDefault: https://academic.oup.com/journals/ providerName: Oxford University Press – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2328-8957 dateEnd: 20241209 omitProxy: false ssIdentifier: ssj0001105079 issn: 2328-8957 databaseCode: 7X7 dateStart: 20140401 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2328-8957 dateEnd: 20241209 omitProxy: false ssIdentifier: ssj0001105079 issn: 2328-8957 databaseCode: BENPR dateStart: 20140401 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Publicly Available Content customDbUrl: eissn: 2328-8957 dateEnd: 20241209 omitProxy: false ssIdentifier: ssj0001105079 issn: 2328-8957 databaseCode: PIMPY dateStart: 20140401 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 2328-8957 dateEnd: 20241209 omitProxy: false ssIdentifier: ssj0001105079 issn: 2328-8957 databaseCode: 8C1 dateStart: 20140401 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1NTxsxEB2VgFAvUAqooRAZqT0hi3htr729VBCIyoEQFVqF08peewEJbYAk_P6ON04gB9pDL5YsW_Jqnz-eZ8bzAL5o2XbKSE6tKDUVqRE0Q2JO26IUyqRCaidqsQnV6-nBIOtHg9sohlXO9sR6o3bDItjID_GcQ7ad4U77_eGRBtWo4F2NEhpLsBwylYkGLB-f9vo_X6wsSB_aKosR73h7P0TIHBbGimDveHUWLbxvCzRzMUjy1anTXf_f7_0Aa5FvkqPpBNmAd776CKvn0aO-CUHP44Z0Ln6fnRBTORLEe2mM0Hr2pIvA3Uw8uYyJDb6RIzJ1J2zBr-7pVecHjWoKtMBLyZhK7VNmLOfMO-NVkrCSSa8ts7jOLdOG2xLJl2eF5Fm7sKlLOStVyTOdGc8d34ZGNaz8JyCpTIxUQpZJ0M_VAi-JyOukK5xwlgnXhIPZf82LmGo8KF7c51OXN88DCnlEoQlf570fpik23uhHEKJ_dNmdgZHHtTjKX5Bowv68GVdRcI2Yyg8nozyROhhEkR43QS3gPh8v5OFebKnubut83FpkqUrlzt8H_wzvkxAPUwcC7kJj_DTxe7BSPI_vRk8tWFIDVZcaS91hrTiVW7WVAGv9s_P-NdauLgZ_ANKC_7I |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3Pb9MwFH4aHQIu_EYrDDASO6FocWzHNhJC00a1amupxEDbKdixs01C6VjbIf4p_kaeG6dbD8BpBy652IqjvM_Pn_2e3wfwWonUSSNYYnmlEp4bnmgk5knKKy5NzoVyfC42IYdDdXioRyvwq70LE9IqW584d9RuXIYz8k1c55Bta_S078--J0E1KkRXWwmNBhZ7_ucP3LJN3vV30L4bWdb7cLC9m0RVgaREcj5NhPI5NZYx6p3xMstoRYVXllrEu6XKMFshCfG0FEynpc1dzmglK6aVNp45hu-9Aascwa46sDrqD0ZHl6c6SFdSqWOGfarZJkLE4cNYHs5Xrqx9S_fpAq1dTsq8ssr17v1v_-c-3I18mmw1E-ABrPj6IdwaxIyBRxD0So7J9scv_R1iakeCOHESM9AuPOkhMI9nnnyKhRveki3ShEsew-dr-e4n0KnHtV8DkovMCMlFlQV9YMVxE4y8VbjScWcpd11409qxKGMp9aDo8a1oQvqsCFYvotW7sLHofdaUEPlDP4KQ-EeX9db4RfQ1k-LS8l14tWhGLxFCP6b249mkQKyGA1-k_12QSzhbjBfqjC-31Kcn83rjiutc5uLp3wd_Cbd3Dwb7xX5_uPcM7mQh92ee9LgOnen5zD-Hm-XF9HRy_iJOGgJfrxuHvwEcs1aF |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long+COVID+and+Post-infective+Fatigue+Syndrome%3A+A+Review&rft.jtitle=Open+forum+infectious+diseases&rft.au=Sandler%2C+Carolina+X&rft.au=Wyller%2C+Vegard+B+B&rft.au=Moss-Morris%2C+Rona&rft.au=Buchwald%2C+Dedra&rft.date=2021-10-01&rft.pub=Oxford+University+Press&rft.eissn=2328-8957&rft.volume=8&rft.issue=10&rft_id=info:doi/10.1093%2Fofid%2Fofab440 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2328-8957&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2328-8957&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2328-8957&client=summon |